Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India
· Delayed Price · Currency is INR 2,135.20
-21.70 (-1.01%)
Aug 14, 2025, 3:30 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 162.19 billion as of August 15, 2025. Its market cap has increased by 37.25% in one year.
Market Cap
162.19B
Enterprise Value
154.32B
Revenue
19.89B
Ranking
n/a
PE Ratio
28.70
Stock Price
2,135.20
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 162.19B, an increase of 2,896,666.50%. That is a compound annual growth rate of 54.89%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,938.27B |
| Divi's Laboratories | 1,627.99B |
| Cipla | 1,263.32B |
| Apollo Hospitals Enterprise | 1,124.61B |
| Mankind Pharma | 1,020.51B |
| Zydus Lifesciences | 994.96B |
| Fortis Healthcare | 703.62B |
| Alkem Laboratories | 639.37B |